TAYLOR ANDERSON: Open Payments
NPI 1790450906 · AUBURN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 25 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $742
Food & beverage: $565Education: $178
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Astellas Pharma US Inc | 1 | $78 |
| PharmaEssentia USA Corporation | 2 | $65 |
| Aveo Pharmaceuticals, Inc. | 2 | $49 |
| Genmab U.S., Inc. | 2 | $46 |
| Fresenius Kabi USA, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $32 |
| Genentech USA, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: BESREMI, FOTIVDA, Epkinly, ENHERTU, CARVYKTI, Itovebi, KEYTRUDA, NERLYNX.
Industry payments across CA — which companies pay providers there.
